Use access key #2 to skip to page content.

portefeuille (99.69)

biopharma investing

Recs

4

January 12, 2012 – Comments (3)

I have written quite a few posts on biopharma stocks. Apart from the linked stuff and the copies of parts of posts and "pitches" by zzlangerhans they contained little information. I still think providing more "original portefeuille" stuff is hardly useful as I am not all that entertaining and still not all that competent. I am doing alright trying to convert the stuff I read and listen to into "caps" game calls on stocks and virtual and less virtual trades and I might be approaching statistically significant effectiveness in "profitable biopharma investing" (in comparison to placebo in the form of the monkey with darts).

The usual obvious (to me) advantages of biopharma investing is that you get a little drama, somewhat interesting science and decent "financial return", but then again my drama and science preferences and my risk tolerance might not be that common.

Maybe scrolling through the stuff linked below can further support the idea that some money should be put into biopharma stocks ...

http://caps.fool.com/player/zzlangerhans/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/player/portefeuille/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/player/portefeuille2/sectors.aspx?astable=biotechnology&filter=all#biotechnology.

http://caps.fool.com/Blogs/ViewBlog.aspx?t=01007366137242330765.

http://caps.fool.com/Blogs/fund-trades/687712.

3 Comments – Post Your Own

#1) On January 12, 2012 at 2:43 AM, portefeuille (99.69) wrote:

And the fact that almost none of the stocks listed under

http://caps.fool.com/tag/biotechnology.aspx

has a 5 star "caps" game rating and most that do are not really interesting shows that the "caps" game needs better "biopharma analysts". Or I will have to raise the number of active portefeuilles ...

http://caps.fool.com/playerrankings.aspx?pagenum=0&sortcol=4&sortdir=1&filter=24&ws=portefeuille

And contrary to popular belief

Biotechnology Names Dominated The Stock Market Last Year

and not the garbage "dividend investors" or "gold bugs" dream of, hehe ...

Report this comment
#2) On January 12, 2012 at 2:51 AM, portefeuille (99.69) wrote:

NASDAQ Biotech Index.



enlarge

Report this comment
#3) On January 12, 2012 at 11:28 AM, portefeuille (99.69) wrote:

is that

are that

Report this comment

Featured Broker Partners


Advertisement